Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications

Based on the FDA Adverse Event Reporting System Database, a Study on Signal Mining of Adverse Events for Guanylate Cyclase-C Receptor Agonists.

Based on the FDA Adverse Event Reporting System Database, a Study on Signal Mining of Adverse Events for Guanylate Cyclase-C Receptor Agonists.

Journal: Hospital pharmacy
Published: October 16, 2025

Laxative logic: when lifestyle is not enough.

Laxative logic: when lifestyle is not enough.

Journal: Current opinion in gastroenterology
Published: September 29, 2025

Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor: analysis of the FDA Adverse Event Reporting System (FAERS) database.

Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor: analysis of the FDA Adverse Event Reporting System (FAERS) database.

Journal: Expert opinion on drug safety
Published: June 12, 2025

Efficacy and safety of pharmacological therapies for functional constipation in children: a systematic review and meta-analysis.

Efficacy and safety of pharmacological therapies for functional constipation in children: a systematic review and meta-analysis.

Journal: The Lancet. Child & adolescent health
Published: June 09, 2025

Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Drugs
Published: June 04, 2025

Current Treatment Options for Children with Functional Constipation-What Is in the Pipeline?

Current Treatment Options for Children with Functional Constipation-What Is in the Pipeline?

Journal: Children (Basel, Switzerland)
Published: May 27, 2025

A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on food and drug administration adverse event reporting system.

A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on food and drug administration adverse event reporting system.

Journal: Frontiers in pharmacology
Published: May 27, 2025

Drugs and patient's dissatisfaction reporting: From a disproportionality pharmacovigilance analysis to social pharmacology.

Drugs and patient's dissatisfaction reporting: From a disproportionality pharmacovigilance analysis to social pharmacology.

Journal: Therapie
Published: March 20, 2025

Adding a C-terminal amino acid prevents the conformational interconversion of plecanatide analogues.

Adding a C-terminal amino acid prevents the conformational interconversion of plecanatide analogues.

Journal: Chembiochem : a European journal of chemical biology
Published: March 18, 2025

Adding A C-Terminal Amino Acid Prevents the Conformational Interconversion of Plecantide Analogs.

Adding A C-Terminal Amino Acid Prevents the Conformational Interconversion of Plecantide Analogs.

Journal: Chembiochem : a European journal of chemical biology
Published: March 18, 2025

The Safety of Pharmacotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

The Safety of Pharmacotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

Journal: The American journal of gastroenterology
Published: February 25, 2025

Post-marketing safety assessment of constipation drugs: a real-world pharmacovigilance study based on FAERS database.

Post-marketing safety assessment of constipation drugs: a real-world pharmacovigilance study based on FAERS database.

Journal: Expert opinion on drug safety
Published: February 14, 2025
Showing 1-12 of 114

Last Updated: 10/31/2025